Live Breaking News & Updates on Karolinska Development Ab Nasdaq Stockholm

Stay updated with breaking news from Karolinska development ab nasdaq stockholm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Karolinska Development invests in BOOST Pharma, expanding its portfolio

Karolinska Development invests in BOOST Pharma, expanding its portfolio
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Karolinska Institutet , Viktor Drvota , Johan Dighed , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , Rare Pediatric Disease , Orphan Drug Designation , General Counsel ,

Karolinska Development's Annual General Meeting 2024

STOCKHOLM, SWEDEN – May 16, 2024. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held the Annual General Meeting on May 16, 2024. The shareholders have had the right to exercise their voting rights in advance through postal voting pursuant to item 13 in the articles of association. Therefore, shareholders have had the choice to exercise their voting rights at the AGM by attending in person, by postal voting or through a proxy. The following resolutions were passed b ....

Philip Duong , Karolinska Institutet , Johan Dighed , Theresa Tse , Ernst Young Aktiebolag , Viktor Drvota , Hans Wigzell , Anna Lefevre Skj , Ben Toogood , Nomination Committee , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Swedish Companies , Appropriation Of The Company , Annual General Meeting , Young Aktiebolag , Oskar Wall , Euroclear Sweden , Annual General , Swedish Corporate Governance Code , Director Remuneration Report , Nasdaq Stockholm , General Counsel ,

Karolinska Development's portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC

Karolinska Development's portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Umecrine Cognitions , Viktor Drvota , Karolinska Institutet , Johan Dighed , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Nasdaq Stockholm , Umecrine Cognition , Primary Biliary Cholangitis , General Counsel ,

Interim Report - January-March 2024

STOCKHOLM – 26 April 2024. Karolinska Development AB today publishes its Interim Report - January-March 2024. The full report is available on the Company s website. “2024 has begun strongly with. ....

Karolinska Institutet , Viktor Drvota , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , International Conference On Alzheimer , Nasdaq Stockholm , Interim Report , Ossdsign Catalyst , Umecrine Cognition , International Conference , Aprea Therapeutics , Investigational New Drug Application , Primary Biliary Cholangitis , Modus Therapeutics ,

Year-end Report - January-December 2023

STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company s website. “2023 has been a year. ....

Viktor Drvota , Karolinska Institutet , Karolinska Development Ab Nasdaq Stockholm , Us National Institute Of Drug Abuse , Liver International , Karolinska Development , Nasdaq Stockholm , Year End Report , Modus Therapeutics , Umecrine Cognition , Drug Abuse , Delta Opioid Receptor Agonist , Ossdsign Catalyst ,